Tomas Neilan
Physician · Massachusetts General Hospital
Credentials: · · · ·
History
- 2005–2006
- 2001–2004
Research
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Journal of the American College of Cardiology · 2018 · Last of 20 authors · Corresponding · 1,305 citations
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
New England Journal of Medicine · 2020 · 1,045 citations
European Journal of Heart Failure · 2020 · 646 citations
- KR
34 papers
33 papers
32 papers
29 papers
28 papers · 15 as a fellow
- PT
27 papers
27 papers
27 papers · 1 as a fellow
Grants
- 2020–2030
Cardiovascular Diseases Among Patients with Cancer and Patients Living with HIV
National Heart, Lung, and Blood Institute · K24
Contact PI · $882.9K · Massachusetts General Hospital
- 2026–2030
The Impact on Cardiovascular Health with Different Hemodialysis Strategies: The TwoPlus CV Study
National Heart, Lung, and Blood Institute · R01
PI · $883.7K · Wake Forest University Health Sciences
- 2022–2027
Immune Checkpoint Inhibitors and Accelerated Coronary Atherosclerosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $5.2M · Massachusetts General Hospital
- 2017–2024
Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.7M · Massachusetts General Hospital
Clinical trials
- 2017–2023
STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
Principal investigator · Completed · Phase 2
Massachusetts General Hospital
- 2013–2018
Cardiac Fibrosis by CMR in Patients With Cancer
Principal investigator · Withdrawn
Massachusetts General Hospital
- 2024–2031